Chapter 44: Endocrine Medications

The content systematically covers medications affecting the pituitary gland, including growth hormone replacements and antidiuretic hormone analogs, with particular attention to fluid balance monitoring and signs of water intoxication. Thyroid function management is addressed through both hormone replacement therapy and drugs that inhibit thyroid hormone synthesis, alongside critical laboratory monitoring parameters and patient education strategies. Calcium regulation medications encompassing supplementation, vitamin D therapy, and bone-resorbing agents are examined in the context of parathyroid dysfunction. Adrenal medications, particularly corticosteroids with their dual mineralocorticoid and glucocorticoid effects, are presented with emphasis on safe tapering protocols, immunosuppression consequences, and metabolic complications including hyperglycemia and bone loss. Reproductive endocrinology coverage includes estrogen, progesterone, and androgen therapies along with various contraceptive delivery systems and their associated drug interactions and contraindications. The diabetes management section forms a substantial portion of the chapter, detailing insulin preparations by onset and duration profiles, proper storage and administration techniques, and safe mixing protocols. Oral antidiabetic medications spanning multiple drug classes are reviewed with their mechanisms and adverse effect profiles. Injectable agents including glucagon-like peptide-1 agonists and amylin analogs receive focused attention regarding administration timing, gastrointestinal effects, and hypoglycemia risk. Emergency glucagon administration for severe hypoglycemia and client education about recognizing endocrine medication side effects complete the chapter content designed to prepare nurses for clinical application and examination success.